-
ReValving that is, percutaneously implanting a new heart valve over a defective valve instead of cutting it out has the potential to one day redefine valve replacement surgery, changing it from a very complex surgical procedure to a relatively simple, less invasive one.
-
Boston Scientific (Natick, Massachusetts) in mid-July reported a substantially widened recall of its lucrative Taxus paclitaxel-eluting coronary stent.
-
Travelers presenting 3 to 4 weeks in advance for travel to areas with high prevalences for hepatitis A and B can benefit from an accelerated dosing schedule using either monovalent or combined hepatitis A and B vaccines. Those who present 2 weeks in advance can be fully protected against hepatitis A; they should be encouraged to begin the vaccine series for hepatitis B even though optimal levels of hepatitis B immunity cannot be provided.
-
A randomized, controlled trial involving North American students visiting Mexico suggests that a restricted diet does not shorten the duration or severity of symptoms during travelers diarrhea.
-
Abiomed (Danvers, Massachusetts) has appointed Karim Benali, MD, vice president of product development and Vincent Wong director of commercial software engineering. Benali previously held several global positions in R&D, product management and new product development at GE Healthcare.
-
The number of patients who could benefit from cardiac resynchronization therapy (CRT) with and without defibrillator backup could dramatically increase if results of a new worldwide clinical trial sponsored by Medtronic (Minneapolis, Minnesota) are positive.
-
After benign positional vertigo, vestibular neuritis is the most common cause of peripheral vestibular vertigo, with an estimated incidence of 3.5 per 100,000 in one study.
-
The computerized interpretation for the ECG in the Figure read, Atrial fibrillation with PVCs (premature ventricular contractions). Do you agree?
-
-
The objective of this prospective, single-center, randomized trial was to compare the efficacy of sodium bicarbonate with sodium chloride as the hydration fluid to prevent contrast-induced nephropathy.
